Table 3 Clinical findings in patients with TC
From: Analysis of 25 surgical cases of thymic neuroendocrine tumors and thymic carcinoma
Age (years)/ Sex | Histology | Tumor size (mm) | Preoperative therapy | Resection status | Combined resection | Masaoka stage | Postoperative therapy | Relapse site | Prognosis (Survival time, days) | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
CT | RT (Gy) | Effect | CT | RT (Gy) | |||||||||
1 | 48 M | Adsq | 35 | − | − | R0 | L, PN, RLN, SA | 3 | − | − | − | A(9) | |
2 | 39 M | Sq | 78 | − | − | R0 | L, PC, PN | 3 | − | 60 | Distant | D(412) | |
3 | 72 M | Sq | 80 | − | − | R0 | L | 2 | − | 50 | − | A(449) | |
4 | 65 M | Sq | 28 | − | − | R0 | − | 4b | − | − | Distant | A(544) | |
5 | 66 F | Sq | 35 | − | − | R1 | BCA, BCV, SVC, L, SA, SV, PN, VN | 3 | − | 54 | − | A(647) | |
6 | 56 M | Sq | 75 | CDDP+GEM, CBDCA+ADM | 50 | SD | R1 | BCV, L, PC | 3 | − | − | Local | D(804) |
7 | 53 F | Sq | 20 | − | − | R0 | − | 2 | − | 54 | − | A(849) | |
8 | 76 F | Sq | 35 | − | − | R2 | L | 4a | CBDCA+PTX, S−1 | − | Local | D(1076) | |
9 | 82 F | Sq | 39 | − | − | R0 | PC | 3 | − | − | Distant | D(1176) | |
10 | 78 M | Sq | 66 | − | − | R0 | PC, SVC | 3 | − | 60 | − | A(1194) | |
11 | 59 M | Sq | 70 | − | − | R0 | PC, L | 2 | − | − | − | A(1441) | |
12 | 66 F | Sq | 100 | CDDP+ADM+VCR+CPA, CBDCA+PTX | − | SD | R0 | L | 4b | CBDCA+PTX, CDDP+VP−16 | − | Local | D(1474) |
13 | 49 M | Sq | 60 | − | − | R0 | L | 2 | − | 60 | − | A(1896) | |
14 | 68 F | Sq | 20 | − | − | R0 | − | 1 | − | 50 | − | A(3293) | |
15 | 53 F | Sq | 34 | − | − | R0 | BCV | 3 | CBDCA+nab−PTX, DOC | 50 | Distant | D(3713) | |
16 | 56 F | Sq | 80 | − | − | R0 | L, PL | 4b | − | RT(unknown) | − | A(4939) | |